The reduced Reelin activity also derepressed GSK3β activity, which, in turn, favored τ hyperphosphorylation, an endpoint of the Reelin signaling pathway originally demonstrated by Hiesberger (18) and Beffert (19), and recently validated as a major AD protective mechanism in humans (20). This evidence concerns the gene RELN and Alzheimer disease.